Cancer incidence in patients with precapillary pulmonary hypertension

Pulmonary Hypertension (PH) is classified into distinct phenotypic groups1 and patients with pulmonary arterial hypertension (PAH) belong to group 1 in the classification scheme. Pulmonary veno-occlusive disease (PVOD) and pulmonary capillary hemangiomatosis belong to group 1 ’, PH associated with lung diseases and/or hypoxemia are classified into group 3, and chronic thromboembolic PH (CTEPH) into group 4 1. The incidence of detection of cancer after diagnosis of precapillary PH is unknown and such patients may be exposed to several carcinogens (smoking, alcohol, occu pational exposure).

Source: The Journal of Heart and Lung Transplantation - March 14, 2019 Category: Transplant Surgery Authors: Dr Elodie Bravos, Pr Vincent Cottin, Dr Claire Dauphin, Dr H élène Bouvaist, Dr Julie Traclet, Dr Romain Trésorier, Dr Victor Margelidon-Cozzolino, Miss Souad Bezzeghoud, Dr Kais Ahmad, Dr Sandrine Accassat, Dr Elodie De Magalhaes, Pr Jean-François Mo Source Type: research